Population Representation: Everyone Must Play a Part
The Impact of Trial Design on Interest by Race and Ethnicity
Tackling Trial Diversity Through Higher Innovation Standards
Strategies for Building Greater DE&I in Rare Disease Trials
Rebooting the Statistic That 5% of Eligible Patients Participate in Clinical Trials
eCOA Systems and the CE Mark: Navigating the Regulations
Quality Tolerance Limits: A Review of Industry Trends
Diversity Plans, Sharing for Meaningful Change
Hints on Looming Changes to European Clinical Trial Rules
Is it Time to Adjust Our Approach to Learning?
Applied Clinical Trials March 2023 Issue (PDF)
Maximizing Success in Rare Disease Studies
Clinical Trial Diversity Continues to Face Challenges
A Singular Root Cause Undermines Clinical Trial Success: Leveraging Best Practice from 50 Years of Applied Research